Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia

American Heart Journal

Volumn 137, Issue 3, 1999, Pages 410-418

  Kawaguchi, Akito ^a   Miyatake, Kunio ^a   Yutani, Chikao ^a   Beppu, Shintarou ^a   Tsushima, Motoo ^a   Yamamura, Taku ^a   Yamamoto, Akira ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; AORTOGRAPHY; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; ASCENDING AORTA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOPPLER ECHOCARDIOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOAM CELL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0033044171     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70485-0     Document Type: Article

References (40)

1. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Scriven CR, Beaudet AL, Sly WS, Volle D, editors. The metabolic basis of inherited disease. 6th ed. New York: MacGraw-Hill; 1989. p 1195-250.
2. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47
3. Goldstein JL. The cardiac manifestation of homozygous and heterozygous forms of familial type II hyperbetalipoproteinemia. Birth Defect 1972;8:202-8.
4. Stone N L, Levy RI, Fredrickson DS, et al. Coronary disease in 16 kindred with familial hypercholesterolemia. Circulation 1974;49:476-88.
5. Jensen J, Blankenhom DH, Kornerup V. Coronary disease in familial hypercholesterolemia. Circulation 1967;36:77-82.
6. Hirobe K, Matsuzawa Y, Ishikawa K, et al. Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis 1982;44:201-10.
7. Cook CD, Smith HL, Giesen CW, et al. Xanthoma tuberosum, aortic stenosis, coronary sclerosis and angina pectoris: report of a case in a boy 13 years of age. Am J Dis Child 1947;73:326-33.
8. Rothbard S, Hagstrom JWC, Smith J P. Aortic stenosis and myocardial infarction in hypercholesterolemic xanthomatosis. Am Heart J 1967;73:687-92.
9. Barr DP, Rothbard S, Eder HA. Atherosclerosis and aortic stenosis in hypercholesterolemic xanthomatosis. JAMA 1954;156:943-7.
10. Boas EP, Elster SK, Adlersberg D. Calcific aortic stenosis: study of serum cholesterol with observation on calcific aortic stenosis in familial xanthomatosis hypercholesterolemia. Am Heart J 1965;48:485-96.
11. Stanley P, Chartland C, Davington A. Acquired aortic stenosis in a twelve-year-old girl with xanthomatosis: successful surgical correction. N Engl J Med 1965;273:1378-80.
12. Mahr JA, Epstein FH, Hand EA. Xanthomatosis and coronary heart disease: necropsy studies of two affected siblings. Arch Intern Med 1958;102:437-42.
13. Wennvold A, Jacobson JG. Acquired supravalvular aortic stenosis in familial hypercholesterolemia. Am J Cardiol 1971;50:823-7
14. Beppu S, Nimura Y, Sakakibara H, et al. Supravalvular aortic stenosis in familial hypercholesterolemia: two-dimensional echocardiographic assessment. Circulation 1983;67:878-84.
15. Miyatake K, Okamoto M, Kinoshita N, et al. Clinical application of a new type of real-time two-dimensional Doppler flow imaging system. Am J Cardiol 1984;54:857-68.
16. Miyake, Tajima S, Yamamura T, et al. Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein. Proc Natl Acad Sci U S A 1981;78:5151-5.
17. Gorlin R, Gorlin G. Hydraulic formula for calculation of area of stenotic mitral valve, other cardiac valves and central circulatory shunts. Am Heart J 1951;41:1-29.
18. Sellers RD, Levy MJ, Amplatz K, et al. Left retrograde cardioangiography in acquired cardiac disease: technique, indication and interpretations in 700 cases. Am J Cardiol 1964;14:437-47
19. American Heart Association Committee Report. A reporting system on patients evaluated for coronary artery disease. Circulation 1975;51:7-34.
20. Mabuchi H, Ito S, Haba T, et al. Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles tendon thickness. Atherosclerosis 1977;28:61-8.
21. Braunwald E. Valvular heart disease. In: Braunwald E, editor. Heart disease. A textbook of cardiovascular medicine. Philadelphia: WB Sounders; 1980. p 1095-165.
22. Aliain CC, Poon LS, Chan CSG, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
23. Buccolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973;19:476-82.
24. Brustein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoprotein from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-95.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
26. Hatle L, Angelsen B. Doppier ultrasound in cardiology. 2nd ed. Philadelphia: Lea & Febiger; 1982.
27. Perry GJ, Helmcke F, Manda NV, et al. Evaluation of aortic insufficiency by Doppler color flow imaging. J Am Coll Cardiol 1987;9:952-9.
28. Sakakibara H, Miyatake K, Izumi S, et al. Assessment of mitral and aortic regurgitation by real-time two-dimensional Doppler flow imaging. Circulation 1984;70(suppl):406.
29. Stamler J, Wentworth D, Neaton JD, for the MRFIT cooperative research group. Is the relationship between serum cholesterol and risk of death from coronary heart disease continuous and graded? Finding on the 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8.
30. Akasaka T, Yoshikawa J, Yoshida K, et al. Age-related valvular regurgitation: a study by pulsed Doppler echocardiography. Circulation 1987;76:262-5.
31. Yoshida K, Yoshikawa J, Shakudo K, et al. Color Doppler evaluation of valvular regurgitation in normal subjects. Circulation 1988;78:840-7
32. Yutani C, Go S, Imakita M, et al. Autopsy findings in two patients with homozygous familial hypercholesterolemia: special references to apoprotein B localization and internalization defect of low density lipoprotein. Acta Pathol Jpn 1987;39:1489-504.
33. Roberts WC, Ferrans VJ, Levy RI, et al. Cardiovascular pathology in hyperpoproteinemia: anatomic observation in 42 necropsy patients with normal or abnormal lipoprotein patterns. Am J Cardiol 1973;31:557-70.
34. Buja LM, Kovanen PT, Bilheimer DW. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol 1987;97:327-58.
35. Yamamoto A, Kamiya T, Yamamura T, et al. Clinical feature of familial hypercholesterolemia. Arteriosclerosis 1989;9:1-66-74.
36. + antiport in human platelets: a novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation 1997;95:1370-7
37. Bellhouse BJ, Talbot L The fluid mechanics of the aortic valve. J Fluid Mech 1965;35:721-35.
38. Allen JM, Thompson GR, Myant NB, et al. Cardiovascular complication of homozygous familial hypercholesterolemia. Br Heart J 1980;44:361-8.
39. Sugrue DD, Thompson GR, Oakley CM, et al. Contrasting pattern of coronary atherosclerosis in normocholesterolemic smokers and patients with hypercholesterolemia. Br Heart J 1981;283:1358-60.
40. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular feature of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 1984;54:20-30.